Personalized drugs: How are they priced?
Fortune's Susie Gharib sits down with Novartis CEO Joseph Jimenez to talk about the company's advancements and what medicine personalization means for consumers.
Joe, there's a lot of excitement about personalized medicine and what people call precision medicine, drugs that are targeted to a person's genetic makeup. Is this close to reality or is it a pipe dream? No, it's not only close to reality. It actually is the reality now. We're now able to identify ...